Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Baxter International, Inc. 

One Baxter Parkway

Deerfield  Illinois  60015  U.S.A.
Phone: 847-948-2000 Fax: 847-948-3642


Baxter International, Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

Business Overview:

Baxter is a leading manufacturer of plasma-based and recombinant proteins used to treat hemophilia. Other biopharmaceutical products include plasma-based therapies to treat immune disorders, alpha 1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Baxter also is a leading manufacturer of manual and automated blood and blood-component separation and collection systems.

Medication Delivery
Baxter is a leading manufacturer of intravenous (IV) solutions and administration sets, premixed drugs and drug reconstitution systems, pre-filled vials and syringes for injectable drugs, electronic infusion pumps, and other products used to deliver fluids and drugs to patients. The company also provides IV nutrition solutions, containers and compounding systems and services; general anesthetic agents and critical care drugs; contract manufacturing services, and drug packaging and formulation technologies.

Baxter is a leading manufacturer of products for peritoneal dialysis (PD), a home therapy for people with end-stage renal disease, or irreversible kidney failure. These products include a range of PD solutions and related supplies to help patients safely perform solution exchanges, as well as automated PD cyclers that perform solution exchanges for patients overnight while they sleep. Baxter also distributes instruments and disposables, including dialyzers, for hemodialysis, generally conducted in a hospital or clinic.

Because of our commitment to research and development, Baxter’s history is rich with medical firsts, from the first commercially manufactured intravenous (IV) solutions to the first portable kidney dialysis machine, plus many more. Baxter continually pursues breakthrough technologies through research facilities around the world, and our investments reflect that commitment.

 Key Statistics

Ownership: Public

Web Site: Baxter International
Symbol: BAX



 Company News
Baxter International (BAX) Files For European Approval Of Investigational 20% Subcutaneous Immune Globulin Treatment For Primary Immunodeficiency 5/21/2015 11:30:03 AM
Baxter International (BAX) And Baxalta Highlight Business Strategies At Investor Conferences 5/18/2015 11:59:18 AM
Baxter International (BAX) Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP From Sabinanigo, Spain, Facility For The U.S. Market 5/18/2015 11:39:09 AM
Baxter International (BAX) Release: Economists Anthony Culyer And Alan Maynard Named Co-Recipients Of The 2015 William B. Graham Prize For Health Services Research 5/13/2015 8:24:56 AM
Baxter International (BAX) To Host May 2015 Investor Conferences 5/12/2015 12:29:51 PM
Baxter International (BAX) Puts Down $900 Million to Beef Up Cancer Products for Spinoff 5/12/2015 7:53:16 AM
Baxter International (BAX) Declares Quarterly Dividend 5/5/2015 11:17:35 AM
Baxter International (BAX) Declares Quarterly Dividend 5/5/2015 8:57:52 AM
Baxter International (BAX) To Host May 2015 Investor Conferences 5/1/2015 11:11:56 AM
Baxter International (BAX) Reports First Quarter Financial Results That Exceed Guidance 4/23/2015 1:08:14 PM